Stock Financial Ratios

INCR / INC Research Holdings, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)3,289.99
Enterprise Value ($M)3,236.47
Book Value ($M)301.47
Book Value / Share5.42
Price / Book1.09
NCAV ($M)821.78
NCAV / Share14.78
Price / NCAV0.52
Income Statement (mra) ($M)
Net Income112.63
Balance Sheet (mrq) ($M)
Cash & Equivalents304.33
Cash / Share5.47
Quick Ratio1.12
Current Ratio1.12
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.14
Return on Assets (ROA)0.09
Return on Equity (ROE)0.37
Identifiers and Descriptors
Central Index Key (CIK)1610950
Industry Groups
SIC 8731 - Commercial Physical and Biological Research
Other Related CUSIPS
Share Statistics
Common Shares Outstanding (M)104.34
Scoring Models
Piotroski F Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Work In Progress Per Share0.00
Intangibles Per Share25.08
Property Plant And Equipment Net Per Share3.11
Treasury Stock Per Share0.00
Cash And Equivalents Per Share5.47
Deferred Income Tax Liabilities Per Share0.00
Assets Per Share130.83
Retained Earnings Per Share-6.36
Liabilities And Stock Equity Per Share131.22
Assets Current Per Share24.51
Additional Paid In Capital Per Share61.22
Goodwill Per Share76.70
Accumulated Depreciation And Depletion Per Share1.39
Liabilities Other Non Current Per Share2.50
Current Portion Of Long Term Debt Per Share0.55
Equity Per Share54.42
Minority Interest Per Share0.00
Cash Per Share5.47
Accounts Receivable Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Current Per Share19.31
Property Plant And Equipment Per Share3.11
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Assets Other Non Current Per Share1.44
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Long Term Debt Per Share53.67
Property Plant And Equipment Gross Per Share4.50
Debt Per Share54.23
Liabilities Per Share75.88

Related News Stories

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INC Research Holdings, Inc. (INCR)

2017-11-13 accesswire
NEW YORK, NY / ACCESSWIRE / November 13, 2017 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: (17-0)

INC Research Holdings 2017 Q3 - Results - Earnings Call Slides

2017-11-10 seekingalpha
The following slide deck was published by INC Research Holdings in conjunction with their 2017 Q3 earnings call. (2-0)

Vapid Sales Growth Limit INC Research Holdings (INCR) Rating

2017-11-09 investorplace
Currently, INC Research Holdings Inc (NASDAQ:INCR) has a Hold using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. INCR has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold. (2-0)

Why Earnings Season Could Be Great for INC Research Holdings (INCR)

2017-11-08 zacks
Investors are always looking for stocks that are poised to beat at earnings season and INC Research Holdings, Inc. (INCR - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because INC Research Holdings is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. (20-0)

Can DENTSPLY (XRAY) Deliver a Beat This Earnings Season?

2017-11-02 zacks
DENTSPLY SIRONA Inc.’s (XRAY - Free Report) third-quarter 2017 results, scheduled for release on Nov 3, are expected to show lackluster performance by dental consumables and laboratories — one of the major revenue-generating components. While this could majorly impact third-quarter earnings, an expected improvement in revenues at other segments should help the company post solid numbers. (8-1)

CUSIP: 45329R109